Kangstem Biotech Co., Ltd. (KOSDAQ:217730)

Kangstem Biotech Revenue

Kangstem Biotech had revenue of 805.01M KRW in the quarter ending March 31, 2026, a decrease of -64.62%. This brings the company's revenue in the last twelve months to 3.42B, down -74.22% year-over-year. In the year 2025, Kangstem Biotech had annual revenue of 3.57B, down -53.88%.

• Revenue (ttm): 3.42B
• Revenue Growth: -74.22%
• P/S Ratio: 73.64
• Revenue / Employee: 35.29M
• Employees: 97
• Market Cap: 252.07B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	3.57B	-4.17B	-53.88%
Dec 31, 2024	7.75B	-4.96B	-39.03%
Dec 31, 2023	12.70B	-3.60B	-22.06%
Dec 31, 2022	16.30B	3.90B	31.41%
Dec 31, 2021	12.40B	3.27B	35.75%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 12, 2026

Data Sources Report a data error